Zobrazeno 1 - 4
of 4
pro vyhledávání: '"H P G Pennings"'
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172488 (2017)
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innovation activities of Big Pharma firms. The study ind
Externí odkaz:
https://doaj.org/article/9b964b109230472d81fbbb31547dff1c
Autor:
L. J. O. Lint, H. P. G. Pennings
Publikováno v:
MAB, Vol 72, Iss 1/2, Pp 60-66 (1998)
Externí odkaz:
https://doaj.org/article/bf2a66cafb6b480aa770829a82589c02
Autor:
L. J. O. Lint, H. P. G. Pennings
Publikováno v:
MAB, Vol 71, Iss 3, Pp 117-125 (1997)
Externí odkaz:
https://doaj.org/article/7820c7fa56b644d89217e67e5a26d832
Publikováno v:
Fernald, K D S, Pennings, H P G, van den Bosch, J F, Commandeur, H R & Claassen, H J H M 2017, ' The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance ', PLoS ONE, vol. 12, no. 2, e0172488, pp. e0172488 . https://doi.org/10.1371/journal.pone.0172488
PLoS ONE, 12(2):e0172488. Public Library of Science
PLoS One (print), 12(2), 1-22. Public Library of Science
PLoS ONE, Vol 12, Iss 2, p e0172488 (2017)
PLoS ONE
PLoS ONE, 12(2):e0172488. Public Library of Science
PLoS One (print), 12(2), 1-22. Public Library of Science
PLoS ONE, Vol 12, Iss 2, p e0172488 (2017)
PLoS ONE
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innovation activities of Big Pharma firms. The study ind